Literature DB >> 19232005

Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea.

Gong Je Seong1, Sae Heun Rho, Chang Sik Kim, Jong Il Moon, Michael Scott Kook, Yong Yeon Kim, Kyoung Tak Ma, Young Jae Hong, Lindsay A Nelson, Bonnie Kruft, Jeanette A Stewart, William C Stewart.   

Abstract

PURPOSE: The aim of this study was to evaluate the potential benefit of intraocular pressure (IOP) reduction in normal tension glaucoma (NTG) Asian adult patients in South Korea.
METHODS: This was a retrospective, multicenter analysis of 166 NTG Asian adult patients in South Korea. The patient population consisted of Korean patients with NTG with at least 5 years of records available for evaluation. Patients all had typical glaucomatous optic-disc and/or visual-field changes but had never had a recorded IOP >21 mmHg.
RESULTS: Overall, 48 (29%) patients were progressed and 116 (71%) were stable over the follow-up period. Of patients with IOPs <or=14 mmHg (21/93), 23% progressed and >or=15 mmHg (27/73) 37% progressed (P = 0.041). The mean IOP for the stable group was 14.0 +/- 1.8 mmHg, whereas with the progressed group the average mean IOP was 14.4 +/- 1.6 mmHg (P = 0.20). The mean peak IOP was 17.4 +/- 2.2 mmHg in the stable group and 17.8 +/- 2.0 mmHg in the progressed group (P = 0.26). Multivariate linear regression analysis did not any identify independent risk factors for progression, including age, gender, or mean and peak IOP.
CONCLUSIONS: This study provides initial evidence that Korean patients with normal-tension glaucoma, treated to lower IOPs, may have a decreased incidence of progression over 5 years than those patients with higher IOPs. More research is required to confirm this finding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19232005     DOI: 10.1089/jop.2008.0056

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  5 in total

1.  Twenty-four-hour intraocular pressure and ocular perfusion pressure characteristics in newly diagnosed patients with normal tension glaucoma.

Authors:  L Quaranta; A Katsanos; I Riva; A Dastiridou; F Oddone; G Roberti; A G P Konstas
Journal:  Eye (Lond)       Date:  2016-07-29       Impact factor: 3.775

2.  Intraocular pressure reduction in normal-tension glaucoma patients in South Korea.

Authors:  Kyoung Tak Ma; Chan Yun Kim; Gong Je Seong; Seung Hyuck Lee; Jong Woon Park; Seung Joo Ha; Byung Joo Cho; Jeanette A Stewart; Michael S Kristoffersen; Lindsay A Nelson; William C Stewart
Journal:  Int Ophthalmol       Date:  2011-09-08       Impact factor: 2.031

Review 3.  Neuroprotection for treatment of glaucoma in adults.

Authors:  Dayse F Sena; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2017-01-25

Review 4.  Neuroprotection for treatment of glaucoma in adults.

Authors:  Dayse F Sena; Kanchan Ramchand; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2010-02-17

Review 5.  Neuroprotection for treatment of glaucoma in adults.

Authors:  Dayse F Sena; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.